Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 32285 [2021-12767]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 115 / Thursday, June 17, 2021 / Notices
partially exclusive license. Objections
submitted in response to this notice will
not be made available to the public for
inspection and, to the extent permitted
by law, will not be released under the
Freedom of Information Act.
FOR FURTHER INFORMATION CONTACT:
Written objections relating to the
prospective license or requests for
further information may be submitted to
Agency Counsel for Intellectual
Property, NASA Headquarters at Email:
hq-patentoffice@mail.nasa.gov.
Questions may be directed to Helen
Galus at (202) 358–3437.
SUPPLEMENTARY INFORMATION: NASA
intends to grant an exclusive, coexclusive, or partially exclusive patent
license in the United States to practice
the inventions described and claimed
in: US 8,735,116 B2, High-Density Spot
Seeding for Tissue Model Formation
and US 9,243,223 B2, High-Density Spot
Seeding for Tissue Model Formation to
BSK Health Partners, LLC. having its
principal place of business in North
Richland Hills, Texas. The fields of use
may be limited. NASA has not yet made
a final determination to grant the
requested license and may deny the
requested license even if no objections
are submitted within the comment
period.
This notice of intent to grant an
exclusive, co-exclusive or partially
exclusive patent license is issued in
accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i). The patent rights in
these inventions have been assigned to
the United States of America as
represented by the Administrator of the
National Aeronautics and Space
Administration. The prospective license
will comply with the requirements of 35
U.S.C. 209 and 37 CFR 404.7.
Information about other NASA
inventions available for licensing can be
found online at https://
technology.nasa.gov.
Helen M. Galus,
Agency Counsel for Intellectual Property.
BILLING CODE 7510–13–P
NUCLEAR REGULATORY
COMMISSION
lotter on DSK11XQN23PROD with NOTICES1
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
public teleconference meeting of the
VerDate Sep<11>2014
18:41 Jun 16, 2021
Jkt 253001
The teleconference meeting will
be held on Thursday, July 15, 2021, 1:00
p.m. to 3:00 p.m. Eastern Daylight Time.
DATES:
Date
Webinar information
July 15, 2021 ....
Link: https://
usnrc.webex.com.
Event number: 199 085
4780.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2021.html on or about August 31, 2021.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. Jamerson of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in 10 CFR
part 7.
Dated at Rockville, Maryland this 14th day
of June, 2021.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2021–12767 Filed 6–16–21; 8:45 am]
BILLING CODE 7590–01–P
Public Participation: The meeting will
also be held as a webinar. Any member
of the public who wishes to participate
in any portion of this meeting should
register in advance of the meeting by
accessing the provided link and event
number above. Upon successful
registration, an email confirmation will
be generated providing the telephone
bridge line and a link to join the
webinar on the day of the meeting.
Members of the public should also
monitor the NRC’s Public Meeting
Schedule at https://www.nrc.gov/pmns/
mtg for any meeting updates. If there are
any questions regarding the meeting,
please contact Ms. Jamerson using the
information below.
Contact Information: Kellee Jamerson,
email: Kellee.Jamerson@nrc.gov,
telephone: 301–415–7408.
Conduct of the Meeting
[FR Doc. 2021–12756 Filed 6–16–21; 8:45 am]
SUMMARY:
Advisory Committee on the Medical
Uses of Isotopes (ACMUI) on July 15,
2021, to discuss the ACMUI
Subcommittee on Extravasations and
Medical Event Reporting draft report on
the NRC staff’s preliminary evaluation
of whether extravasations merits a
change in medical event reporting. The
meeting agenda is subject to change.
Meeting information, including a copy
of the agenda and related documents,
will be available on the ACMUI’s
Meetings and Related Documents web
page at https://www.nrc.gov/reading-rm/
doc-collections/acmui/meetings/
2021.html. The agenda and related
meeting documents may also be
obtained by contacting Ms. Kellee
Jamerson using the information below.
32285
The ACMUI Chair, Darlene F. Metter,
M.D., will preside over the meeting. Dr.
Metter will conduct the meeting in a
manner that will facilitate the orderly
conduct of business. The following
procedures apply to public participation
in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Jamerson at the
contact information listed above. All
written statements must be received by
July 12, 2021, three business days prior
to the meeting, and must pertain to the
topics on the agenda for the meeting.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
NUCLEAR REGULATORY
COMMISSION
[Docket No. 40–8907; NRC–2019–0026]
United Nuclear Corporation Church
Rock Project
Nuclear Regulatory
Commission.
ACTION: Draft environmental impact
statement; reopening of comment
period.
AGENCY:
On November 13, 2020, the
U.S. Nuclear Regulatory Commission
(NRC) issued for public comment a draft
Environmental Impact Statement (EIS)
for United Nuclear Corporation’s (UNC)
license amendment request. The public
comment period closed on May 27,
2021. The NRC has decided to re-open
the public comment period to allow
more time for members of the public to
develop and submit their comments.
UNC is requesting authorization to
amend its license (SUA–1475) to
excavate approximately 1 million cubic
yards (CY) of mine waste from the
Northeast Church Rock Mine Site and
dispose of it at the existing mill site in
McKinley County, New Mexico. The
NRC plans to hold a public meeting in
the future to promote full understanding
of the contemplated action and facilitate
public comment.
DATES: The comment period for the
document published on November 13,
SUMMARY:
E:\FR\FM\17JNN1.SGM
17JNN1
]]>Agencies
[Federal Register Volume 86, Number 115 (Thursday, June 17, 2021)]
[Notices]
[Page 32285]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12767]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
public teleconference meeting of the Advisory Committee on the Medical
Uses of Isotopes (ACMUI) on July 15, 2021, to discuss the ACMUI
Subcommittee on Extravasations and Medical Event Reporting draft report
on the NRC staff's preliminary evaluation of whether extravasations
merits a change in medical event reporting. The meeting agenda is
subject to change. Meeting information, including a copy of the agenda
and related documents, will be available on the ACMUI's Meetings and
Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html. The agenda and related meeting
documents may also be obtained by contacting Ms. Kellee Jamerson using
the information below.
DATES: The teleconference meeting will be held on Thursday, July 15,
2021, 1:00 p.m. to 3:00 p.m. Eastern Daylight Time.
------------------------------------------------------------------------
Date Webinar information
------------------------------------------------------------------------
July 15, 2021......................... Link: https://usnrc.webex.com.
Event number: 199 085 4780.
------------------------------------------------------------------------
Public Participation: The meeting will also be held as a webinar.
Any member of the public who wishes to participate in any portion of
this meeting should register in advance of the meeting by accessing the
provided link and event number above. Upon successful registration, an
email confirmation will be generated providing the telephone bridge
line and a link to join the webinar on the day of the meeting. Members
of the public should also monitor the NRC's Public Meeting Schedule at
https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any
questions regarding the meeting, please contact Ms. Jamerson using the
information below.
Contact Information: Kellee Jamerson, email:
[email protected], telephone: 301-415-7408.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the
meeting. Dr. Metter will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson at the contact information listed
above. All written statements must be received by July 12, 2021, three
business days prior to the meeting, and must pertain to the topics on
the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about August 31, 2021.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Jamerson of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in 10
CFR part 7.
Dated at Rockville, Maryland this 14th day of June, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-12767 Filed 6-16-21; 8:45 am]
BILLING CODE 7590-01-P
